(NASDAQ: OFIX) Orthofix Medical's forecast annual revenue growth rate of 4.93% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.88%.
Orthofix Medical's revenue in 2026 is $825,374,000.On average, 7 Wall Street analysts forecast OFIX's revenue for 2026 to be $34,769,896,617, with the lowest OFIX revenue forecast at $33,180,113,044, and the highest OFIX revenue forecast at $36,006,394,952. On average, 7 Wall Street analysts forecast OFIX's revenue for 2027 to be $36,517,728,850, with the lowest OFIX revenue forecast at $34,562,533,543, and the highest OFIX revenue forecast at $37,929,252,938.
In 2028, OFIX is forecast to generate $38,614,804,156 in revenue, with the lowest revenue forecast at $35,869,769,768 and the highest revenue forecast at $40,358,190,006.